Indications for Radioactive Iodine in the Management of Thyroid Cancer

  • RECOMMENDATION 51 of the American Thyroid Association
    • RAI remnant ablation is not routinely recommended after thyroidectomy for ATA low-risk DTC patients:
      • Consideration of specific features of the individual patient that could modulate recurrence risk, disease follow-up implications, and patient preferences are relevant to RAI decision-making
    • RAI remnant ablation is not routinely recommended after lobectomy or total thyroidectomy for patients with unifocal papillary microcarcinoma, in the absence of other adverse features.
    • RAI remnant ablation is not routinely recommended after thyroidectomy for patients with multifocal papillary microcarcinoma in absence of other adverse features:
      • Consideration of specific features of the individual patient that could modulate recurrence risk, disease follow-up implications, and patient preferences are relevant to RAI decision-making
    • RAI adjuvant therapy should be considered after total thyroidectomy in ATA intermediate-risk level DTC patients
    • RAI adjuvant therapy is routinely recommended after total thyroidectomy for ATA high risk DTC patients

#Arrangoiz #CancerSurgeon #ThyroidSurgeon #ThyroidExpert #ThyroidCancer #HeadandNeckSurgeon #CASO #CenterforAdvancedSurgicalOncology

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s